Hard capsules are rigid, cylindrical shells typically made of two parts - body and cap - which are filled with dry or liquid ingredients and then specially sealed to prevent leakages. These are one of the oldest forms of pharmaceutical capsule. Hard-shelled capsules, which contain dry, powdered ingredients or miniature pellets made by e.g. processes of extrusion or spheronization. These are made in two halves: a smaller-diameter “body” that is filled and then sealed using a larger-diameter “cap”.
The global Pharma Hard Capsules market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The “Pharma Hard Capsules Industry Forecast” looks at past sales and reviews total world Pharma Hard Capsules sales in 2023, providing a comprehensive analysis by region and market sector of projected Pharma Hard Capsules sales for 2024 through 2030. With Pharma Hard Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharma Hard Capsules industry.
This Insight Report provides a comprehensive analysis of the global Pharma Hard Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharma Hard Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharma Hard Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharma Hard Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharma Hard Capsules.
United States market for Pharma Hard Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pharma Hard Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pharma Hard Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pharma Hard Capsules players cover Lonza, Qualicaps, ACG, Suheung, Farmacapsulas SA, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharma Hard Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Stomach-soluble Gelatin Capsules
Enterosoluble Vacant Gelatin Capsules
Other
Segmentation by Application:
Pharmaceutical
Healthcare Products
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Lonza
Qualicaps
ACG
Suheung
Farmacapsulas SA
ERAWAT PHARMA LIMITED
Dah Feng Capsule
Lefan Capsule
Shing Lih Fang
Roxlor
Nectar Lifesciences
Kangke
Angtai
Tsingtao Capsule
Huangshan Capsule
MEIHUA Group
Yili Capsule
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharma Hard Capsules market?
What factors are driving Pharma Hard Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharma Hard Capsules market opportunities vary by end market size?
How does Pharma Hard Capsules break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharma Hard Capsules Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pharma Hard Capsules by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pharma Hard Capsules by Country/Region, 2019, 2023 & 2030
2.2 Pharma Hard Capsules Segment by Type
2.2.1 Stomach-soluble Gelatin Capsules
2.2.2 Enterosoluble Vacant Gelatin Capsules
2.2.3 Other
2.3 Pharma Hard Capsules Sales by Type
2.3.1 Global Pharma Hard Capsules Sales Market Share by Type (2019-2024)
2.3.2 Global Pharma Hard Capsules Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pharma Hard Capsules Sale Price by Type (2019-2024)
2.4 Pharma Hard Capsules Segment by Application
2.4.1 Pharmaceutical
2.4.2 Healthcare Products
2.4.3 Other
2.5 Pharma Hard Capsules Sales by Application
2.5.1 Global Pharma Hard Capsules Sale Market Share by Application (2019-2024)
2.5.2 Global Pharma Hard Capsules Revenue and Market Share by Application (2019-2024)
2.5.3 Global Pharma Hard Capsules Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Pharma Hard Capsules Breakdown Data by Company
3.1.1 Global Pharma Hard Capsules Annual Sales by Company (2019-2024)
3.1.2 Global Pharma Hard Capsules Sales Market Share by Company (2019-2024)
3.2 Global Pharma Hard Capsules Annual Revenue by Company (2019-2024)
3.2.1 Global Pharma Hard Capsules Revenue by Company (2019-2024)
3.2.2 Global Pharma Hard Capsules Revenue Market Share by Company (2019-2024)
3.3 Global Pharma Hard Capsules Sale Price by Company
3.4 Key Manufacturers Pharma Hard Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharma Hard Capsules Product Location Distribution
3.4.2 Players Pharma Hard Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pharma Hard Capsules by Geographic Region
4.1 World Historic Pharma Hard Capsules Market Size by Geographic Region (2019-2024)
4.1.1 Global Pharma Hard Capsules Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pharma Hard Capsules Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pharma Hard Capsules Market Size by Country/Region (2019-2024)
4.2.1 Global Pharma Hard Capsules Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pharma Hard Capsules Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pharma Hard Capsules Sales Growth
4.4 APAC Pharma Hard Capsules Sales Growth
4.5 Europe Pharma Hard Capsules Sales Growth
4.6 Middle East & Africa Pharma Hard Capsules Sales Growth
5 Americas
5.1 Americas Pharma Hard Capsules Sales by Country
5.1.1 Americas Pharma Hard Capsules Sales by Country (2019-2024)
5.1.2 Americas Pharma Hard Capsules Revenue by Country (2019-2024)
5.2 Americas Pharma Hard Capsules Sales by Type (2019-2024)
5.3 Americas Pharma Hard Capsules Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharma Hard Capsules Sales by Region
6.1.1 APAC Pharma Hard Capsules Sales by Region (2019-2024)
6.1.2 APAC Pharma Hard Capsules Revenue by Region (2019-2024)
6.2 APAC Pharma Hard Capsules Sales by Type (2019-2024)
6.3 APAC Pharma Hard Capsules Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharma Hard Capsules by Country
7.1.1 Europe Pharma Hard Capsules Sales by Country (2019-2024)
7.1.2 Europe Pharma Hard Capsules Revenue by Country (2019-2024)
7.2 Europe Pharma Hard Capsules Sales by Type (2019-2024)
7.3 Europe Pharma Hard Capsules Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharma Hard Capsules by Country
8.1.1 Middle East & Africa Pharma Hard Capsules Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pharma Hard Capsules Revenue by Country (2019-2024)
8.2 Middle East & Africa Pharma Hard Capsules Sales by Type (2019-2024)
8.3 Middle East & Africa Pharma Hard Capsules Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharma Hard Capsules
10.3 Manufacturing Process Analysis of Pharma Hard Capsules
10.4 Industry Chain Structure of Pharma Hard Capsules
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharma Hard Capsules Distributors
11.3 Pharma Hard Capsules Customer
12 World Forecast Review for Pharma Hard Capsules by Geographic Region
12.1 Global Pharma Hard Capsules Market Size Forecast by Region
12.1.1 Global Pharma Hard Capsules Forecast by Region (2025-2030)
12.1.2 Global Pharma Hard Capsules Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Pharma Hard Capsules Forecast by Type (2025-2030)
12.7 Global Pharma Hard Capsules Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Lonza
13.1.1 Lonza Company Information
13.1.2 Lonza Pharma Hard Capsules Product Portfolios and Specifications
13.1.3 Lonza Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Lonza Main Business Overview
13.1.5 Lonza Latest Developments
13.2 Qualicaps
13.2.1 Qualicaps Company Information
13.2.2 Qualicaps Pharma Hard Capsules Product Portfolios and Specifications
13.2.3 Qualicaps Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Qualicaps Main Business Overview
13.2.5 Qualicaps Latest Developments
13.3 ACG
13.3.1 ACG Company Information
13.3.2 ACG Pharma Hard Capsules Product Portfolios and Specifications
13.3.3 ACG Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 ACG Main Business Overview
13.3.5 ACG Latest Developments
13.4 Suheung
13.4.1 Suheung Company Information
13.4.2 Suheung Pharma Hard Capsules Product Portfolios and Specifications
13.4.3 Suheung Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Suheung Main Business Overview
13.4.5 Suheung Latest Developments
13.5 Farmacapsulas SA
13.5.1 Farmacapsulas SA Company Information
13.5.2 Farmacapsulas SA Pharma Hard Capsules Product Portfolios and Specifications
13.5.3 Farmacapsulas SA Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Farmacapsulas SA Main Business Overview
13.5.5 Farmacapsulas SA Latest Developments
13.6 ERAWAT PHARMA LIMITED
13.6.1 ERAWAT PHARMA LIMITED Company Information
13.6.2 ERAWAT PHARMA LIMITED Pharma Hard Capsules Product Portfolios and Specifications
13.6.3 ERAWAT PHARMA LIMITED Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 ERAWAT PHARMA LIMITED Main Business Overview
13.6.5 ERAWAT PHARMA LIMITED Latest Developments
13.7 Dah Feng Capsule
13.7.1 Dah Feng Capsule Company Information
13.7.2 Dah Feng Capsule Pharma Hard Capsules Product Portfolios and Specifications
13.7.3 Dah Feng Capsule Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Dah Feng Capsule Main Business Overview
13.7.5 Dah Feng Capsule Latest Developments
13.8 Lefan Capsule
13.8.1 Lefan Capsule Company Information
13.8.2 Lefan Capsule Pharma Hard Capsules Product Portfolios and Specifications
13.8.3 Lefan Capsule Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Lefan Capsule Main Business Overview
13.8.5 Lefan Capsule Latest Developments
13.9 Shing Lih Fang
13.9.1 Shing Lih Fang Company Information
13.9.2 Shing Lih Fang Pharma Hard Capsules Product Portfolios and Specifications
13.9.3 Shing Lih Fang Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shing Lih Fang Main Business Overview
13.9.5 Shing Lih Fang Latest Developments
13.10 Roxlor
13.10.1 Roxlor Company Information
13.10.2 Roxlor Pharma Hard Capsules Product Portfolios and Specifications
13.10.3 Roxlor Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Roxlor Main Business Overview
13.10.5 Roxlor Latest Developments
13.11 Nectar Lifesciences
13.11.1 Nectar Lifesciences Company Information
13.11.2 Nectar Lifesciences Pharma Hard Capsules Product Portfolios and Specifications
13.11.3 Nectar Lifesciences Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Nectar Lifesciences Main Business Overview
13.11.5 Nectar Lifesciences Latest Developments
13.12 Kangke
13.12.1 Kangke Company Information
13.12.2 Kangke Pharma Hard Capsules Product Portfolios and Specifications
13.12.3 Kangke Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kangke Main Business Overview
13.12.5 Kangke Latest Developments
13.13 Angtai
13.13.1 Angtai Company Information
13.13.2 Angtai Pharma Hard Capsules Product Portfolios and Specifications
13.13.3 Angtai Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Angtai Main Business Overview
13.13.5 Angtai Latest Developments
13.14 Tsingtao Capsule
13.14.1 Tsingtao Capsule Company Information
13.14.2 Tsingtao Capsule Pharma Hard Capsules Product Portfolios and Specifications
13.14.3 Tsingtao Capsule Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Tsingtao Capsule Main Business Overview
13.14.5 Tsingtao Capsule Latest Developments
13.15 Huangshan Capsule
13.15.1 Huangshan Capsule Company Information
13.15.2 Huangshan Capsule Pharma Hard Capsules Product Portfolios and Specifications
13.15.3 Huangshan Capsule Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Huangshan Capsule Main Business Overview
13.15.5 Huangshan Capsule Latest Developments
13.16 MEIHUA Group
13.16.1 MEIHUA Group Company Information
13.16.2 MEIHUA Group Pharma Hard Capsules Product Portfolios and Specifications
13.16.3 MEIHUA Group Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 MEIHUA Group Main Business Overview
13.16.5 MEIHUA Group Latest Developments
13.17 Yili Capsule
13.17.1 Yili Capsule Company Information
13.17.2 Yili Capsule Pharma Hard Capsules Product Portfolios and Specifications
13.17.3 Yili Capsule Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Yili Capsule Main Business Overview
13.17.5 Yili Capsule Latest Developments
14 Research Findings and Conclusion
Ěý
Ěý
*If Applicable.
